Burfiralimab Antibody
Burfiralimab (hzVSF-v13) is an anti-vascular stromal fibroblast (VSF) IgG4 monoclonal antibody with demonstrated anti-HBV activity. It serves as a research tool for investigating rheumatoid arthritis and related autoimmune pathologies, with utility in both in vitro cellular assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
HzVSF-v13, HBV
Target
Interleukin, SARS-CoV, HBV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Infectious Disease & Virology
Concentration
9.82 mg/mL
Purity
90.00% (May vary between batches)
Molecular Weight
144.6 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
134939 1 Pack (1 Panel (s) x 1 Pack)
E/E032/NT-PP-PHOLUMB-150X150/1-B Marine & IMO Signs (No Adhesive)
Sign In for Pricing
View Details K2471505 3x 1.0 µg
TRMT5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details ![Rabbit Polyclonal NAC1 Antibody [PerCP]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
MBS6001258-01 0.2 mL
TRIM13, NT (TRIM13, LEU5, RFP2, RNF77, E3 ubiquitin-protein ligase TRIM13, B-cell chronic lymphocytic leukemia tumor suppressor Leu5, Leukemia-associated protein 5, Putative tumor suppressor RFP2, RING finger protein 77, Ret finger protein 2, Tripartite m
Sign In for Pricing
View Details